ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Special Issue: Pharmacoproteomics in personalised medicine


Pharmacoproteomics is essentially the amalgamation of the basic and applied concepts of proteomics and pharmaceutical sciences. Most pharmacoproteomic studies are intended to analyze the clinical efficacy and bio-molecular compatibility of a specific drug. These studies involves proteomic profiling of a target individual, a group of individuals or sometimes an entire population, to analyze their susceptibility or resistance for a particular disease or a particular drug.

Pharmacoproteomics studies provided the basic knowledge required for the study and application of personalized medicine in real time cases. The underlying concept that lead to the conceptualization of personalized medicine is based on the fact that, though more than 99% of the human genome is conserved, the seemingly minor changes in the rest 1% determines how each individual is different from the rest. The Human Genome Project helped in identifying and understanding these genetic polymorphisms, especially in the key metabolic genes. It also explained why the administration of the same therapeutic agent in different individuals does not necessarily imply the same effect in two or more individuals.

This special issue is focused on the publication of the latest research findings that showcases the concepts and applications of proteomics, pharmacoproteomics, genetic and proteomic basis of personalized medicine as well as the contemporary application of these concepts in the treatment of hitherto incurable acute and chronic diseases. The journal invites manuscripts that are based on conventional and contemporary methods and practices of pharmacoproteomics and personalized medicine, to be published in the upcoming special issue of the Journal of Pharmacogenomics and Pharmacoproteomics.


Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version